This multicenter study led by Andreas H. Kramer and his colleagues delves into the critical practice of administering premortem heparin to potential organ donors in controlled donation after circulatory determination of death (DCD). Despite its widespread use, the practice remains controversial due to the potential risk of inducing bleeding and the lack of solid evidence…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest